The use of estrogen antagonists in hormone receptor studies.
D000818:Animals; D000840:Anisoles / Q000494:pharmacology; D001667:Binding, Competitive; D001943:Breast Neoplasms / Q000188:drug therapy; D002996:Clomiphene / Q000494:pharmacology*; D003600:Cytosol / Q000378:metabolism; D004965:Estrogen Antagonists; D004967:Estrogens / Q000627:therapeutic use; D000431:Ethanol / Q000494:pharmacology*; D005021:Ethylamines / Q000494:pharmacology; D005260:Female; D006801:Humans; D009281:Naphthalenes / Q000494:pharmacology; D010636:Phenols / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011956:Receptors, Cell Surface; D013343:Styrenes / Q000494:pharmacology; D014316:Tritium; D014599:Uterus / Q000187:drug effects*
D000840:Anisoles; D004965:Estrogen Antagonists; D004967:Estrogens; D005021:Ethylamines; D009281:Naphthalenes; D010636:Phenols; D011759:Pyrrolidines; D011956:Receptors, Cell Surface; D013343:Styrenes; D014316:Tritium; D002996:Clomiphene; D000431:Ethanol